Bonnie Kam
Director, Strategic HTA, Janssen
Bonnie Kam serves as Director, Health Technology Assessment leading the Health Economics & HTA team within the Market Access group at Janssen. Bonnie is currently in role as the Vice-Chair of the Joint HTA IMC-BIOTECanada committee on behalf of industry. Prior to joining Janssen’s Government Affairs & Market Access Team, Bonnie comes from a background in regulatory affairs through positions held at Procter & Gamble Inc., Warner Chilcott Canada, and Coca-Cola Ltd. Bonnie obtained her Bachelor of Science, Toxicology from the University of Toronto.
Bonnie Kam serves as Director, Health Technology Assessment leading the Health Economics & HTA team within the Market Access group at Janssen. Bonnie is currently in role as the Vice-Chair of the Joint HTA IMC-BIOTECanada committee on behalf of industry. Prior to joining Janssen’s Government Affairs & Market Access Team, Bonnie comes from a background in regulatory affairs through positions held at Procter & Gamble Inc., Warner Chilcott Canada, and Coca-Cola Ltd. Bonnie obtained her Bachelor of Science, Toxicology from the University of Toronto.
